<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of this study was to retrospectively analyze brain magnetic resonance imaging (MRI) findings in patients who developed neurologic complications after liver and kidney transplantation </plain></SENT>
<SENT sid="1" pm="."><plain>The results in 216 organ transplant recipients, who had brain MRI were evaluated retrospectively </plain></SENT>
<SENT sid="2" pm="."><plain>We performed 187 brain MRI on kidney recipients and 29 liver recipients </plain></SENT>
<SENT sid="3" pm="."><plain>Neuroradiologic findings were classified in three groups: group 1 findings were related to transplantation; group 2 findings, to <z:hpo ids='HP_0011010'>chronic</z:hpo> parenchymal disease; and group 3 to neither transplantation nor <z:hpo ids='HP_0011010'>chronic</z:hpo> parenchymal disease </plain></SENT>
<SENT sid="4" pm="."><plain>In group 1, six patients (20.6%) after liver and three (1.6%) after kidney transplantation had posterior reversible <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> syndrome; two patients (1.1%) after renal and one (3.4%) after liver transplantation had <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculosis</z:e> granulomas; one patient (0.5%) after renal transplantation had osmotic <z:hpo ids='HP_0011096'>demyelination</z:hpo> syndrome; one patient (0.5%) had a Nocardia abcess and one (0.5%) focal <z:e sem="disease" ids="C0742115" disease_type="Disease or Syndrome" abbrv="">cerebritis</z:e> after renal transplantation </plain></SENT>
<SENT sid="5" pm="."><plain>Among group 2, 38 patients (20.3%) had brain <z:mpath ids='MPATH_127'>atrophy</z:mpath>; 37 (20%), white matter changes; 3 (1.6%), sinus <z:mp ids='MP_0005048'>thrombosis</z:mp>; 8 (4.3%), lacunar <z:mpath ids='MPATH_124'>infarct</z:mpath>; 1 (0.5%), had <z:e sem="disease" ids="C0035086" disease_type="Disease or Syndrome" abbrv="">renal osteodystrophy</z:e> in the cranial bones; and 4 (2.2%), had <z:hpo ids='HP_0002170'>intracranial hemorrhage</z:hpo> secondary to <z:hpo ids='HP_0003774'>end-stage renal disease</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Brain <z:mpath ids='MPATH_127'>atrophy</z:mpath> in nine patients (31%), hyperintensity in the globus pallidus on T1-weighted <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> images owing to <z:chebi fb="70" ids="18291,35154">manganese</z:chebi> deposits in nine patients (31%), hyperintensity in basal ganglia on T2-weighted <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> images owing to <z:mpath ids='MPATH_38'>copper depositions</z:mpath> in one patient (3.4%) were seen secondary to <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver disease</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>In group 3, three patients (1.6%) had intracranial <z:hpo ids='HP_0012032'>lipomas</z:hpo>; one (0.5%), mesial temporal <z:mp ids='MP_0000612'>sclerosis</z:mp>; and one (0.5%), an anterior <z:hpo ids='HP_0004944'>cerebral artery aneurysm</z:hpo> in renal transplant patients </plain></SENT>
<SENT sid="8" pm="."><plain>Periventricular and subcortical white matter hyperintensities were observed on T2-weighted <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> images in six liver transplant patients (20.7%) </plain></SENT>
<SENT sid="9" pm="."><plain>Neurologic complications after organ transplantation may be secondary to transplantation itself, to <z:hpo ids='HP_0011010'>chronic</z:hpo> parenchymal disease, or to neither transplantation nor <z:hpo ids='HP_0011010'>chronic</z:hpo> parenchymal disease </plain></SENT>
</text></document>